The chemical chaperone sodium 4-phenylbutyrate improves the secretion of the protein C mutant in CHO-K1 cells trough the GRASP55 pathway by unknown
Chollet et al. Cell Biosci  (2015) 5:57 
DOI 10.1186/s13578-015-0048-4
LETTER TO THE EDITOR
The chemical chaperone sodium 
4-phenylbutyrate improves the secretion of the 
protein CA267T mutant in CHO-K1 cells trough 
the GRASP55 pathway
Maria Eugenia Chollet1,2*, Ellen Skarpen3, Nina Iversen4, Per Morten Sandset1,5 and Grethe Skretting1,2
Abstract 
Some inherited coagulation factor deficiencies are caused by intracellular retention or degradation of misfolded 
proteins, and chemical chaperones have been shown to reverse protein misfolding. The purpose of the present study 
was to investigate whether chemical chaperones may improve secretion of the protein CA267T (PCA267T) mutant in a 
cellular model. Using stably transfected Chinese hamster ovary cells (CHO-K1) expressing PCA267T we demonstrate 
that sodium 4-phenylbutyrate (PBA) increased the secretion of PCA267T by approximately 4-fold in comparison with 
untreated cells, and that this secretion seemed to follow an unconventional pathway via the Golgi reassembly stack-
ing protein (GRASP55).
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Dear Editor,
In order to determine whether chemical chaperones 
were able to restore secretion of the PCA267T mutant, 
we treated Chinese hamster ovary cells (CHO-K1) sta-
bly expressing PC wild type (PCwt) or PCA267T [1] with 
3 different compounds: Sodium 4-phenylbutyrate 
(PBA), trimethylamine N-oxide (TMAO) and taurouro-
sdeoxycholic acid (TUDCA). While no effect was seen 
with TMAO or TUDCA, treatment with PBA for 48  h 
enhanced the secretion of PCA267T. Our data indicate that 
PBA can rescue the trafficking of this mutant PC via an 
unconventional pathway involving the Golgi reassembly 
stacking protein GRASP55.
Several diseases are caused by defective protein folding 
leading to excessive protein degradation by proteasomes 
or to aggregation of misfolded proteins inside or outside 
the cell [2].
In some inherited coagulation factor deficiencies, fail-
ure of the mutant protein to adopt its properly folded 
state has been demonstrated. Our group has previously 
described the protein CA267T (PCA267T) mutant in a 
patient with congenital PC deficiency and recurrent deep 
vein thrombosis [3]. We found that this mutant, PCA267T, 
was retained in the endoplasmic reticulum (ER), most 
likely due to misfolding of the protein. This caused ER 
stress, activation of the unfolded protein response and 
apoptosis [1, 4]. Moreover, in hemophilia A, a domain-
specific misfolding in the FVIII A3 domain caused ER 
retention of the mutant FVIII with poor secretion of the 
functional protein [5].
Recently, several therapeutic strategies using small 
molecules able to correct or prevent misfolding of a pro-
tein, have been explored. Amongst them are chemical 
chaperones, which are low molecular mass compounds 
that effectively are able to inhibit the formation of mis-
folded structures and reverse the intracellular retention 
of misfolded proteins [6]. Therefore, chemical chaper-
ones could be effective in reversing misfolding of blood 
coagulation proteins.
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Since our previous studies have shown a defective traf-
ficking of the PC A267T mutant [4] we tested a possible 
effect of chemical chaperones on the secretion of this 
mutant protein. Thus, CHO-K1 cells stably expressing 
PCwt and the mutant PCA267T were treated with PBA at 1, 
2, and 5 mM for 48 h, trimethylamine N-oxide (TMAO) 
at 25 and 50 mM for 24 h and taurourosdeoxycholic acid 
(TUDCA) at 0.2 and 0.5  mM for 16  h. Untreated cells 
were used as control. The concentrations of PC antigen 
in the culture medium were measured using the Zymut-
est Protein C kit and the total protein concentration of 
the cell lysates was measured by the BCA Protein Assay 
kit. PC antigen levels in culture medium were normalized 
to the total concentration of protein of the respective cell 
lysates. Three independent experiments were performed 
in triplicates. Results were tested for statistical signifi-
cance using one-way ANOVA or Student’s t test. P values 
<0.05 were considered statistically significant. GraphPad 
Prism version 5 was used for statistical analysis.
No effect was observed with TMAO or TUDCA treat-
ment. In contrast, treatment with PBA for 48 h enhanced 
the secretion of PCA267T in a dose dependent manner 
(Fig. 1). A small increase in the secretion of PCwt was also 
observed (data not shown).
Studies have shown that PBA can reverse the cellular 
mislocalization or misfolding of proteins. For example, PBA 
treatment increased the secretion of ER retained α1-ATZ 
in a cell and mouse model of mutant alpha 1-antitrypsin-
Z (α1-ATZ) [7]. Thus, for the PCA267T mutant, the positive 
effect of PBA on secretion of the mutant protein can proba-
bly be related to a stabilization of the protein conformation 
by PBA, which can facilitate the trafficking of the protein. 
This might be a general effect of PBA since the secretion of 
the PCwt was also found to be slightly increased.
Since our group previously demonstrated that PCA267T 
was retained in the ER [4], we hypothesized that PBA 
treatment could restore the normal intracellular traffick-
ing of the mutated protein. Thus, we assessed the intra-
cellular localization of PCA267T after PBA treatment by 
confocal microscopy using double staining for PC (rabbit 
polyclonal anti-PC) and a marker for ER (mouse mono-
clonal anti-protein disulfide isomerase, PDI), or for PC 
and a Golgi marker (mouse monoclonal anti-GM-130). 
Alexa Fluor 488 goat anti-rabbit and Alexa fluor 568 
donkey anti-mouse were used as secondary antibodies. 
Prior to PBA treatment we found that PCA267T was pre-
dominantly localized in the ER compartment (Fig.  2A, 
a–c) as previously described [4], while another fraction of 
PCA267T was found associated with Golgi (Fig.  2B, a–c). 
After treating the cells with PBA, PCA267T showed a more 
cytoplasmic distribution pattern (Fig.  2A, B, compare a 
and d). To assess whether the cytoplasmic localization 
of PCA267T could be caused by its redistribution from 
the ER and/or Golgi compartments, we did co-locali-
zation analysis on merged images of PCA267T combined 
with either PDI or GM130 before and after PBA treat-
ment. As shown in Fig. 2C, the fraction of PCA267T that 
co-localized with PDI was strongly reduced (Manders 
from 0.76 to 0.47) after treatment with PBA. In addi-
tion, the fraction of PCA267T that co-localized with the 
Golgi compartment was also reduced (Manders from 0.4 
to 0.16). No differences were observed in the fraction of 
PCwt that co-localized with the ER after PBA treatment 
(data not shown). For the fraction of PCwt that co-local-
ized with Golgi, only a slight and non-significant reduc-
tion was observed (Manders from 0.29 to 0.19) after PBA 
treatment. Thus, our results suggest that PBA caused a 
redistribution of PCA267T from both ER and Golgi to the 
cytoplasm. The small effect of PBA on the redistribution 
of PCwt might be due to a small fraction of the normal 
protein that is incorrectly folded.
Interestingly, we observed that the cytoplasmic locali-
zation of PCA267T was to some extent associated with 
vesicles (Fig. 2A, B, d). Since it is known that some pro-
teins can be secreted through unconventional pathways, 
such as lysosomes and exosomes, phospholipid mediated 
direct translocation, microvesicles, autophagosomes [8], 
or the recently discovered GRASP55-dependent path-
way [9], we aimed to identify the origin of the vesicles 
that could potentially be involved in the secretion of 
the PCA267T mutant. We therefore performed a double 
Fig. 1 PBA improved the secretion of PCA267T. CHO-K1 cells stably 
expressing PCA267T were incubated with indicated concentrations of 
PBA for 48 h. The levels of PC in the cell medium were determined 
using an ELISA kit. The results are presented as % PC relative to the 
PC levels in a plasma pool from healthy subjects (set as 100 %) and 
adjusted to the total protein concentrations in corresponding cell 
lysates. Results from three independent experiments are presented 
as mean ± SEM relative to untreated control cells. *p < 0.05, 
***p < 0.0005
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staining of PBA-treated cells with PC combined with 
Rab11 (mouse monoclonal anti-Rab11), Rab8a (mouse 
monoclonal anti-Rab8a,) or GRASP55 (mouse monoclo-
nal anti-Grasp55). While no co-localization was observed 
for PC with either Rab11 or Rab8a (data not shown), co-
localization was detected for PC and GRASP55, both in 
vesicles and in the perinuclear areas (Fig. 2D). In the PCwt, 
the presence of some cytoplasmic vesicles that showed 
co-localization of PC and GRASP55 was also observed 
after PBA treatment, but to a much lesser extent com-
pared to the PCA267T mutant (Fig. 3). These findings sug-
gest that PBA treatment can promote the secretion of the 
PCA267T mutant through an unconventional GRASP55 
dependent pathway. The role of GRASP55 in such uncon-
ventional secretion of certain proteins has been outlined. 
It was reported in a cell and mouse model of the cystic 
fibrosis transmembrane conductance regulator (CFTR) 
∆F508 mutant, which is misfolded and retained in the 
ER, that this mutated protein can be transported to the 
cell surface via a GRASP55 dependent unconventional 
pathway [10]. In studies in Drosophila cells GRASP has 
been found at ER exit sites and it has been proposed that 
GRASP can act as a tethering factor for ER-derived carri-
ers before their fusion with the plasma membrane [9]. By 
knocking down GRASP proteins, it was shown that they 
play a role in protein glycosylation and sorting of cargo 
molecules at the trans-Golgi network [11]. As mentioned 
above, the involvement of GRASP55 in unconventional 
secretion of proteins has also been reported in mamma-
lian cells and mice models [10].
Fig. 2 PBA treatment resulted in relocalization of PCA267T from the ER and Golgi to GRASP55-positive vesicles. Confocal images from PC (green) 
and PDI (red)-stained (A), PC (green) and GM130 (red)-stained (B), or PC (green) and GRASP55 (red)-stained (D) CHO-K1 cells stably transfected with 
PC-A267T untreated (A, B, a–c) or treated with 5 mM PBA for 48 h (A, B, d–f, D, a–c). A Cells were stained with rabbit polyclonal anti-PC (a, d), and 
mouse monoclonal anti-PDI (b, e), and merged images of green and red are shown in c, f. Co-localized green and red pixels are shown in yellow color. 
B Cells were stained with rabbit polyclonal anti-PC (a, d) and mouse monoclonal anti-GM130 (b, e), and merged images are shown in c, f. Three 
independent experiments were performed. Bar 20 µm. C The co-localization of PC with PDI or GM130 was calculated based on the merged (c, f) 
images in A and B, by the Manders’ co-localization coefficient. Results are presented statistically as the mean ± SEM of at least three independent 
experiments. *p < 0.05 Students’ t test comparing PBA-treated cells relative to non-treated (ctrl) cells in the PC/PDI-stained samples. **p < 0.05 Stu-
dents’ t test comparing PBA-treated cells relative to non-treated (ctrl) cells in PC/GM130-stained samples. D Cells were stained with rabbit polyclonal 
anti-PC (a), and mouse monoclonal anti-GRASP55 (b). Merged images of a and b are shown in c, with co-localized green and red pixels shown in 
yellow color. Zoomed images of the vesicles are shown in a′–c′. Three independent experiments were performed. Bar in a–c 5 µm. Bar in a′–c′ 2 µm
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In conclusion, we report here for the first time that 
PBA improved the secretion of the PCA267T mutant 
through an unconventional GRASP55 dependent way. 
Most likely, this is achieved by a process involving stabi-
lization of the protein conformation, which would facili-
tate the intracellular trafficking of the mutant. Functional 
studies are required to verify the activity of the secreted 
PCA267T mutant and also to determine a possible benefi-
cial therapeutic role of PBA in protein C deficiency and 
other coagulation factor deficiencies in which the genetic 
defect causes a misfolding of the protein.
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Fig. 3 PBA treatment caused some localization of PCwt in GRASP55 positive vesicles. Confocal images from PC (green) (a) and GRASP55 (red) (b) 
stained CHO-K1 cells stably transfected with PCwt and treated with 5 mM PBA for 48 h. Cells were stained with rabbit polyclonal anti-PC (a), and 
mouse monoclonal anti-GRASP55 (b). Merged images of a and b are shown in c, with co-localized green and red pixels shown in yellow color. Three 
independent experiments were performed. Bar in a–c 5 µm
